Here's Why Insulet Corporation's Investors Are Pumped
In response to the company's upbeat third-quarter results and raised guidance, shares of Insulet Corporation (NASDAQ: PODD), a medical device maker focused on diabetes and drug delivery, rose 16% as of 11:55 a.m. EDT on Friday.
Here are the key takeaways from Insulet's third quarter:
Management expects the good times to continue into the fourth quarter. The company is projecting revenue to land between $123 million and $126 million, which represents 20% at the midpoint. This range compares favorably to Wall Street's estimate of $120.9 million.
Source: Fool.com
Insulet Corp. Stock
€185.35
0.790%
Insulet Corp. is currently one of the favorites of our community with 16 Buy predictions and no Sell predictions.
With a target price of 215 € there is a slightly positive potential of 16.0% for Insulet Corp. compared to the current price of 185.35 €.
